FOR PATIENTS

Welcome to our dedicated resource hub for newly diagnosed patients.

You’ve been diagnosed. Now what?

A NUT carcinoma diagnosis can feel overwhelming—but you’re not alone.

This diagnosis is rare, but you’re now connected to a global network of researchers, advocates, and families all working toward the same goal: a future with better treatments—and one day, a cure.

illustration of a globe with circling hearts

Find Support

Discovering the right support can make a significant difference in your journey. Connect with organizations and communities that understand your experience and can provide the resources you need.

First Steps After a NUT Carcinoma Diagnosis

There are steps you can take right now to connect with experts, contribute to research, and find support as you navigate treatment. Here’s where to start:

Questions to Ask Your Oncologist

Question:

Can I get a second opinion from a center that specializes in NUT carcinoma?

Because NUT carcinoma is so rare, most oncologists have never treated a case before. Getting a second opinion from specialists who understand this cancer can make a huge difference in your care. We strongly recommend:

Contact Dana-Farber Cancer Institute —They discovered NUT carcinoma and have the world’s leading team of specialists who have treated the most patients

Contact UNC Lineberger Comprehensive Cancer Center — They also have extensive experience with NUT carcinoma patients

Ask your current oncologist to consult with these centers — Many doctors are happy to collaborate with specialists when facing a rare cancer they haven’t seen before

Question:

What clinical trials or novel therapies (e.g., BET inhibitors, checkpoint inhibitors) are available for my specific case?

With no established standard of care, clinical trials are often the best option. Discuss:

Are there ongoing trials for BET inhibitors (targeting BRD4/BRD3-NUTM1 fusions) or immunotherapy combinations (e.g., checkpoint inhibitors with chemotherapy)?

How do my tumor’s molecular features (e.g., fusion type, PD-L1 status) influence trial eligibility or targeted therapy options?

If surgery or radiation is feasible, how will these be integrated with systemic therapies?

Question:

How will we balance treatment aggressiveness with quality of life, and what palliative/supportive resources are available?

What are realistic treatment goals (e.g., tumor control vs. symptom management)?

How will side effects of aggressive therapies (e.g., chemotherapy, radiation) be mitigated?

Can you connect me with palliative care specialists to address pain, fatigue, and emotional needs early in my care journey?

Latest News & Events

Keep in touch with the latest news and events from the NUT Carcinoma Alliance.

Maddie Musselman Woepse’s Review of Milken Institute Future of Health Summit

November 5-6, 2025 On Wednesday Nov 5th, I had the honor of...

group of swimmers running into the ocean

First Annual PWF Swim 2025

Event Details DATE/TIME: August 9th, 2025 LOCATION: Newport Beach, CA DESCRIPTION: Swimming...

Max Vincze and family

Why Funding Rare Cancer Research Can’t Wait

In Memory of Max Vincze When Suzanne Vincze lost her 22-year-old son...